Axovan Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $39.8M

Axovan General Information

Description

Operator of a biopharmaceutical research company intended to create novel drugs. The company is involved in the discovery of drugs linked to G protein-coupled receptors, enabling patients to receive drugs at a short span of time.

Contact Information

Website
www.axovan.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Gewerbestrasse 16
  • 4123 Allschwil
  • Switzerland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Gewerbestrasse 16
  • 4123 Allschwil
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Axovan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 31-Oct-2003 $39.8M Completed Generating Revenue
2. Early Stage VC 22-Apr-2002 Completed Generating Revenue
1. Early Stage VC 01-Jun-2000 $4.68M $4.68M Completed Product Development
To view Axovan’s complete valuation and funding history, request access »

Axovan Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Atlas Venture Venture Capital Minority
Banque Cantonale Vaudoise Corporation Minority
Endeavour Vision Venture Capital Minority
HBM Healthcare Investments Venture Capital Minority
HBM Partners Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Axovan FAQs

  • When was Axovan founded?

    Axovan was founded in 2000.

  • Where is Axovan headquartered?

    Axovan is headquartered in Allschwil, Switzerland.

  • What industry is Axovan in?

    Axovan’s primary industry is Drug Discovery.

  • Is Axovan a private or public company?

    Axovan is a Private company.

  • What is the current valuation of Axovan?

    The current valuation of Axovan is .

  • What is Axovan’s current revenue?

    The current revenue for Axovan is .

  • How much funding has Axovan raised over time?

    Axovan has raised $22.7M.

  • Who are Axovan’s investors?

    Atlas Venture, Banque Cantonale Vaudoise, Endeavour Vision, HBM Healthcare Investments, and HBM Partners are 5 of 9 investors who have invested in Axovan.

  • When was Axovan acquired?

    Axovan was acquired on 31-Oct-2003.

  • Who acquired Axovan?

    Axovan was acquired by Actelion Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process